FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC: Form 990, tax year 2014
View the entire original 990 at ProPublica ↗
- Organization
- FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC (EIN 52-1986675)
- Tax period
- 2014-01-01 to 2014-12-31
- Filed
- 2015-11-12
- IRS object ID
- 201513169349304256
- Schema version
- 2014v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2015-11-12T13:58:14-06:00 | ReturnTs |
| Tax Period End | 2014-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 560747981 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DIXON HUGHES GOODMAN LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 111 ROCKVILLE PIKE 6TH FLOOR | AddressLine1Txt |
| City | ROCKVILLE | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20850 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2014-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 521986675 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FOUNDATION FOR THE NATIONAL INSTITUTES | BusinessNameLine1Txt |
| Business Name Line2 | OF HEALTH INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | FOUN | BusinessNameControlTxt |
| Phone | 3014025311 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE NO 3411 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MARIA FREIRE PHD | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 3014025311 | PhoneNum |
| Signature | 2015-11-11 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | LORI K COCHRAN CPA | PreparerPersonNm |
| PTIN | P00853221 | PTIN |
| Phone | 2404033700 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2014 | TaxYr |
| Build TS | 2016-03-07 17:11:31Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | MARIA FREIRE PHD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE NO 3411 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $145,938,597 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | HTTP://WWW.FNIH.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2001 | FormationYr |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Activity Or Mission | THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 31 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 30 | VotingMembersIndependentCnt |
| Total Employee | 49 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $59,135,001 | PYContributionsGrantsAmt |
| CY Contributions Grants | $73,905,546 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $333,361 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $197,177 | CYProgramServiceRevenueAmt |
| PY Investment Income | $199,587 | PYInvestmentIncomeAmt |
| CY Investment Income | $148,518 | CYInvestmentIncomeAmt |
| PY Other Revenue | $150,775 | PYOtherRevenueAmt |
| CY Other Revenue | $199,253 | CYOtherRevenueAmt |
| PY Total Revenue | $59,818,724 | PYTotalRevenueAmt |
| CY Total Revenue | $74,450,494 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $40,276,784 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $57,340,984 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $5,820,510 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $5,868,172 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $126,016 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $14,736,567 | PYOtherExpensesAmt |
| CY Other Expenses | $10,868,336 | CYOtherExpensesAmt |
| PY Total Expenses | $60,833,861 | PYTotalExpensesAmt |
| CY Total Expenses | $74,077,492 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$1,015,137 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $373,002 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $101,581,045 | TotalAssetsBOYAmt |
| Total Assets EOY | $99,015,541 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $10,442,627 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $7,446,160 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $91,138,418 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $91,569,381 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O, STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENT | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $68,198,142 | ExpenseAmt |
| Grant | $55,844,351 | GrantAmt |
| Revenue | $197,177 | RevenueAmt |
| Desc | SEE SCHEDULE O, PROGRAM ONE, RESEARCH PARTNERSHIPS | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,605,067 | ExpenseAmt |
| Grant | $1,339,808 | GrantAmt |
| Desc | SEE SCHEDULE O, PROGRAM TWO, FELLOWSHIPS AND TRAINING PROGRAMS | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $103,421 | ExpenseAmt |
| Desc | SEE SCHEDULE O, PROGRAM THREE, CAPITAL PROJECTS | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $427,057 | ExpenseAmt |
| Grant | $156,825 | GrantAmt |
| Desc | SEE SCHEDULE O, MEMORIALS, AWARDS AND EVENTS | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $427,057 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $156,825 | TotalOtherProgSrvcGrantAmt |
| Total Program Service Expenses | $70,333,687 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | Yes (1) | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | Yes (1) | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (1) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (1) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 41 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 49 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 31 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 30 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JULIE TUNE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3014025311 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (42 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| ANN LURIE | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| ANNE WOJCICKI | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| CHARLES A SANDERS MD | ||||||||
| CHAIRMAN | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| EDISON T LIU MD PHD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| ELLEN V SIGAL PHD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| FREDA C LEWIS-HALL MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| GARRY A NEIL MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| JAMES H DONOVAN | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| JILLIAN SACKLER | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| JOEL S MARCUS | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| JOHN EDWARD PORTER | ||||||||
| VICE CHAIRMAN, POLICY | 1.50 | Yes (X) | $0 | $0 | $0 | |||
| JOSEPH M FECZKO MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| KATHY BLOOMGARDEN | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| LILY SAFRA | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| LUTHER W BRADY MD | ||||||||
| HONORARY DIRECTOR | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| MARTIN J MURPHY JR MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| MILES GILBURNE | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| MR STEVEN C MAYER | ||||||||
| TREASURER | 1.50 | Yes (X) | $0 | $0 | $0 | |||
| MRS WILLIAM MCCORMICK BLAIR JR | ||||||||
| SECRETARY | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| MRS WILLIAM N CAFRITZ | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| NINA SOLARZ | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| PATRICK C WALSH MD | ||||||||
| HONORARY DIRECTOR | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| PAUL BERG PHD | ||||||||
| DIRECTOR EMERITUS | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| PAUL L HERRLING PHD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| PAUL M MONTRONE PHD | ||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| RONALD L KRALL MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| SAMUEL O THIER MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| SHERRY LANSING | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| SOLOMON H SNYDER MD | ||||||||
| VICE CHAIRMAN, SCIENCE | 1.50 | Yes (X) | $0 | $0 | $0 | |||
| STEVEN M PAUL MD | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| MARIA FREIRE PHD | ||||||||
| PRESIDENT | 40.00 | $374,138 | $0 | $26,000 | Yes (X) | |||
| ANDREA BARUCHIN | ||||||||
| SR ADVISOR TO PRESIDENT | 40.00 | $199,543 | $0 | $25,250 | Yes (X) | |||
| ANN ASHBY | ||||||||
| DEPUTY EXECUTIVE DIRECTOR | 40.00 | $210,755 | $0 | $32,595 | Yes (X) | |||
| DAVID WHOLLEY | ||||||||
| DIR RESEARCH PARTNERSHIPS | 40.00 | $284,891 | $0 | $37,520 | Yes (X) | |||
| JULIA WOLF-RODDA | ||||||||
| DIR DEVELOPMENT | 40.00 | $187,834 | $0 | $30,303 | Yes (X) | |||
| JULIE TUNE | ||||||||
| CHIEF FINANCIAL OFFICER | 40.00 | $192,774 | $0 | $30,797 | Yes (X) | |||
| STEPHANIE JAMES | ||||||||
| DIR OF SCIENCE AND GCGH | 40.00 | $288,174 | $0 | $26,000 | Yes (X) | |||
| GAIL LEVINE | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $149,386 | $0 | $26,459 | Yes (X) | |||
| KAREN TOUNTAS | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $152,591 | $0 | $26,779 | Yes (X) | |||
| MARIA VASSILEVA | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $136,960 | $0 | $25,216 | Yes (X) | |||
| MICHAEL GOTTLIEB | ||||||||
| ASSOC DIR OF SCIENCE | 40.00 | $234,143 | $0 | $23,414 | Yes (X) | |||
| STEVE HOFFMAN | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $139,447 | $0 | $25,465 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,550,636 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $335,798 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 14 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| SWOG CTI | |||||
| 24 FRANK LLOYD WRIGHT DRIVE | ANN ARBOR | MI | 48106 | CLINICAL TRIAL | $4,615,196 |
| QUINTILES INC | |||||
| PO BOX 601070 | CHARLOTTE | NC | 28260 | PROJECT MANAGEMENT | $708,038 |
| CCS ASSOCIATES | |||||
| PO BOX 9125 | MCLEAN | VA | 22102 | CONSULTING | $553,140 |
| MARRIOTT BUSINESS SERVICES | |||||
| PO BOX 402642 | ATLANTA | GA | 30384 | MEETING SERVICES | $404,683 |
| THE REGENTS OF THE UNIV OF CALIFORNIA | |||||
| 9500 GILMAN DRMAIL CODE 0009 | LA JOLLA | CA | 92093 | PROJECT MANAGEMENT | $399,943 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 19 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $500,000 | GovernmentGrantsAmt |
| All Other Contributions | $73,405,546 | AllOtherContributionsAmt |
| Total Contributions | $73,905,546 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | ADMINISTRATIVE FEES | Desc |
| Business | 561000 | BusinessCd |
| Total Revenue Column | $197,177 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $197,177 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $197,177 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $214,303 | TotalRevenueColumnAmt |
| Exclusion | $214,303 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $71,282,940 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $71,348,725 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | -$65,785 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$65,785 | TotalRevenueColumnAmt |
| Exclusion | -$65,785 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $184,675 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $139,378 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $45,297 | TotalRevenueColumnAmt |
| Exclusion | $45,297 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | MISCELLANEOUS REVENUE | Desc |
| Business | 541700 | BusinessCd |
| Total Revenue Column | $153,956 | TotalRevenueColumnAmt |
| Exclusion | $153,956 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $153,956 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $74,450,494 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $197,177 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $347,771 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $35,152,112 | TotalAmt |
| Program Services | $35,152,112 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $219,718 | TotalAmt |
| Program Services | $219,718 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,969,154 | TotalAmt |
| Program Services | $21,969,154 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,940,876 | TotalAmt |
| Program Services | $755,061 | ProgramServicesAmt |
| Management And General | $1,182,716 | ManagementAndGeneralAmt |
| Fundraising | $3,099 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,746,045 | TotalAmt |
| Program Services | $1,832,409 | ProgramServicesAmt |
| Management And General | $835,201 | ManagementAndGeneralAmt |
| Fundraising | $78,435 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $458,277 | TotalAmt |
| Program Services | $242,342 | ProgramServicesAmt |
| Management And General | $202,254 | ManagementAndGeneralAmt |
| Fundraising | $13,681 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $417,301 | TotalAmt |
| Program Services | $254,925 | ProgramServicesAmt |
| Management And General | $155,401 | ManagementAndGeneralAmt |
| Fundraising | $6,975 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $305,673 | TotalAmt |
| Program Services | $142,660 | ProgramServicesAmt |
| Management And General | $163,013 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $338,998 | TotalAmt |
| Program Services | $335,915 | ProgramServicesAmt |
| Management And General | $3,083 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $53,500 | TotalAmt |
| Management And General | $53,500 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,000 | TotalAmt |
| Program Services | $15,000 | ProgramServicesAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,251 | TotalAmt |
| Program Services | $13,711 | ProgramServicesAmt |
| Management And General | $9,463 | ManagementAndGeneralAmt |
| Fundraising | $77 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $150,255 | TotalAmt |
| Program Services | $49,561 | ProgramServicesAmt |
| Management And General | $95,593 | ManagementAndGeneralAmt |
| Fundraising | $5,101 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $437,715 | TotalAmt |
| Program Services | $183,785 | ProgramServicesAmt |
| Management And General | $253,930 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,390,625 | TotalAmt |
| Program Services | $1,322,824 | ProgramServicesAmt |
| Management And General | $67,054 | ManagementAndGeneralAmt |
| Fundraising | $747 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $26,542 | TotalAmt |
| Management And General | $26,542 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $171,874 | TotalAmt |
| Program Services | $123,196 | ProgramServicesAmt |
| Management And General | $48,678 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| PROGRAM CONTRACTS | $6,384,946 | $6,384,946 | ||
| CONSULTANTS | $1,502,514 | $1,234,372 | $264,269 | $3,873 |
| RECRUITING | $154,967 | $63,840 | $91,127 | |
| SERVICE CHARGES | $98,342 | $24,582 | $73,760 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $119,807 | TotalAmt |
| Program Services | $13,574 | ProgramServicesAmt |
| Management And General | $92,205 | ManagementAndGeneralAmt |
| Fundraising | $14,028 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $74,077,492 | TotalAmt |
| Program Services | $70,333,687 | ProgramServicesAmt |
| Management And General | $3,617,789 | ManagementAndGeneralAmt |
| Fundraising | $126,016 | FundraisingAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,557,709 | BOYAmt |
| EOY | $20,242,543 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,917,910 | BOYAmt |
| EOY | $19,827,866 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $243,935 | BOYAmt |
| EOY | $101,522 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $662,633 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $608,297 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,016 | BOYAmt |
| EOY | $54,336 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $68,829,475 | BOYAmt |
| EOY | $58,789,274 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $101,581,045 | BOYAmt |
| EOY | $99,015,541 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,735,752 | BOYAmt |
| EOY | $1,338,401 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,340,739 | BOYAmt |
| EOY | $4,605,461 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,196,132 | BOYAmt |
| EOY | $1,338,837 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $170,004 | BOYAmt |
| EOY | $163,461 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,442,627 | BOYAmt |
| EOY | $7,446,160 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,306,798 | BOYAmt |
| EOY | $11,758,572 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $76,604,220 | BOYAmt |
| EOY | $76,594,675 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,227,400 | BOYAmt |
| EOY | $3,216,134 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $91,138,418 | BOYAmt |
| EOY | $91,569,381 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $101,581,045 | BOYAmt |
| EOY | $99,015,541 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $373,002 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $57,961 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $61,850,631 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $59,279,254 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $58,355,026 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $58,635,001 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $73,405,546 | CurrentTaxYearAmt |
| Total | $311,525,458 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $500,000 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $486,000 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $514,000 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $500,000 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $500,000 | CurrentTaxYearAmt |
| Total | $2,500,000 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $62,350,631 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $59,765,254 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $58,869,026 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $59,135,001 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $73,905,546 | CurrentTaxYearAmt |
| Total | $314,025,458 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $159,928,420 | SubstantialContributorsTotAmt |
| Public Support Total170 | $154,097,038 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $173,991 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $134,140 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $140,900 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $213,728 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $214,303 | CurrentTaxYearAmt |
| Total | $877,062 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $314,902,520 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $2,742,095 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.48930 | PublicSupportCY170Pct |
| Public Support PY170 | 0.54000 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Donor Advised Funds Held | 2 | DonorAdvisedFundsHeldCnt |
| Donor Advised Funds Contri | $4,230 | DonorAdvisedFundsContriAmt |
| Donor Advised Funds Grants | $3,100 | DonorAdvisedFundsGrantsAmt |
| Donor Advised Funds Vl EOY | $4,925,017 | DonorAdvisedFundsVlEOYAmt |
| Disclosed Org Leg Ctrl | Yes (1) | DisclosedOrgLegCtrlInd |
| Disclosed For Charitable Prps | Yes (1) | DisclosedForCharitablePrpsInd |
| Agent Trustee Etc | 0 | AgentTrusteeEtcInd |
| Incl Escrow Custodial Acct Liab | Yes (1) | InclEscrowCustodialAcctLiabInd |
| Explanation Provided | Yes (X) | ExplanationProvidedInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,381,374 | BeginningYearBalanceAmt |
| Contributions | $6,271,975 | ContributionsAmt |
| Investment Earnings Or Losses | $11,641 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $48,330 | AdministrativeExpensesAmt |
| End Year Balance | $9,616,660 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,491,739 | BeginningYearBalanceAmt |
| Contributions | $14,559 | ContributionsAmt |
| Investment Earnings Or Losses | -$83,704 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $41,220 | AdministrativeExpensesAmt |
| End Year Balance | $3,381,374 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,498,900 | BeginningYearBalanceAmt |
| Contributions | $15,153 | ContributionsAmt |
| Investment Earnings Or Losses | $25,879 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $48,193 | AdministrativeExpensesAmt |
| End Year Balance | $3,491,739 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,558,830 | BeginningYearBalanceAmt |
| Contributions | $3,214 | ContributionsAmt |
| Investment Earnings Or Losses | -$91 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $63,053 | AdministrativeExpensesAmt |
| End Year Balance | $3,498,900 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,736,712 | BeginningYearBalanceAmt |
| Contributions | $9,744 | ContributionsAmt |
| Investment Earnings Or Losses | -$108,391 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $131,734 | OtherExpendituresAmt |
| Administrative Expenses | $79,235 | AdministrativeExpensesAmt |
| End Year Balance | $3,558,830 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.65000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.33000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.02000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $662,633 | OtherCostOrOtherBasisAmt |
| Depreciation | $608,297 | DepreciationAmt |
| Book Value | $54,336 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $54,336 | TotalBookValueLandBuildingsAmt |
Other Securities OtherSecuritiesGrp (6 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| BOND MUTUAL FUNDS | $591,522 | F |
| EQUITY MUTUAL FUNDS | $269,535 | F |
| CORPORATE BONDS | $213,211 | F |
| GOVERNMENT BONDS | $56,897,792 | F |
| STOCKS | $703,404 | F |
| EXCHANGE TRADED FUNDS | $113,810 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $58,789,274 | TotalBookValueSecuritiesAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | CHARITABLE GIFT ANNUITY | Desc |
| Amt | $163,461 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $163,461 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $76,561,089 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $57,961 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $188,637 | DonatedServicesAndUseFcltsAmt |
| Other Revenue | $1,724,619 | OtherRevenueAmt |
| Revenue Not Reported | $1,971,217 | RevenueNotReportedAmt |
| Revenue Subtotal | $74,589,872 | RevenueSubtotalAmt |
| Other Revenues Not Included | -$139,378 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$139,378 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $74,450,494 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $76,130,126 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $188,637 | DonatedServicesUseFcltsAmt |
| Other Expenses Included | $1,863,997 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $2,052,634 | ExpensesNotReportedAmt |
| Expenses Subtotal | $74,077,492 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $74,077,492 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART IV, LINE 2B: | AS OF 12/31/2014, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC HELD $1,338,837 IN AGENCY FUNDS FOR FUTURE DISTRIBUTIONS TO THE NATIONAL INSTITUTES OF HEALTH (NIH). THESE FUNDS ARE DESIGNATED BY THE FUNDER(S) FOR SPECIFIC PROJECTS AT THE NIH, AND WILL BE DISBURSED AS NEEDED. |
| PART V, LINE 4: | THE FOUNDATION'S ENDOWMENTS CONSIST OF INDIVIDUAL DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR A VARIETY OF PURPOSES. (E.G. VARIETY OF RESEARCH AND EDUCATIONAL INITIATIVES AT THE FOUNDATION FOR THE NIH). NET ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS. |
| PART X, LINE 2: | THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF DECEMBER 31, 2014 AND 2013. FISCAL YEARS ENDING ON OR AFTER DECEMBER 31, 2011 REMAIN SUBJECT TO EXAMINATION BY FEDERAL AND STATE TAX AUTHORIES. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | IN KIND CONTRIBUTIONS |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | FUNDRAISING DIRECT EXPENSE |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | IN KIND CONTRIBUTIONS FUNDRAISING DIRECT EXPENSE |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTMAKING | $11,010,529 |
| EUROPE | 0 | 0 | GRANTMAKING | $10,434,252 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTMAKING | $210,453 |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | $313,920 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continutation Total Office | 0 | ContinutationTotalOfficeCnt |
| Continutation Total Employee | 0 | ContinutationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $21,969,154 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $21,969,154 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (8 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| EUROPE | DEVELOP A GENETIC STRATEGY TO DEPLETE OR INCAPACITATE INSECTS/VIMC2 | $9,416,510 | WIRE TRANSFER |
| SOUTH ASIA | EPIDEMIOLOGY OF VISCERAL LEISMANIASIS PROJECT | $95,211 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | MODIFYING MOSQUITO POPULATION AGE STRUCTURE TO ELIMINATE DENGUE TRANSMISSION-ELIMINATE DENGUE | $10,995,461 | WIRE TRANSFER |
| SOUTH ASIA | EPIDEMIOLOGY OF VISCERAL LEISMANIASIS PROJECT | $218,709 | WIRE TRANSFER |
| EUROPE | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | $477,592 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | BIOMARKERS OSTEOARTHRITIS | $15,068 | WIRE TRANSFER |
| SUB-SAHARAN AFRICA | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | $210,453 | WIRE TRANSFER |
| EUROPE | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | $540,150 | WIRE TRANSFER |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 8 | Total501c3OrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS SOME DEVELOPING COUNTRY INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. | ExplanationTxt |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | 2014- FNIH AWARD CEREMONY | Event1Nm |
| Gross Receipts Event1 | $184,675 | GrossReceiptsEvent1Amt |
| Gross Revenue Event1 | $184,675 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $17,422 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $121,956 | OtherDirectExpensesEvent1Amt |
| Gross Receipts Total | $184,675 | GrossReceiptsTotalAmt |
| Gross Revenue Total Events | $184,675 | GrossRevenueTotalEventsAmt |
| Food And Beverage Total Events | $17,422 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $121,956 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $139,378 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | $45,297 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (26 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|
| NIHNIA | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $13,050,991 | RESEARCH | |
| NIHNIAID | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $4,072,380 | RESEARCH | |
| NIHNHLBI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $4,050,877 | RESEARCH | |
| NIHNIAMS | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $3,000,000 | RESEARCH | |
| NIHNINDS | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $2,858,899 | RESEARCH | |
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 615 N WOLFE ST W1100 | BALTIMORE | MD | 21205 | 150595110 | 501(C)(3) | $1,266,704 | MAL-ED | |
| NIH- CLINICAL CENTER | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $1,033,784 | RESEARCH | |
| NIHNCI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $835,326 | RESEARCH | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||
| 1855 FOLSOM STREET/MCB425- BOX 0897 | SAN FRANCISCO | CA | 94143 | 946036493 | 501(C)(3) | $545,000 | OSTEOARTHRITIS/BONE QUALITY | |
| NIHFIC | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $538,507 | RESEARCH | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | $529,119 | VIMC/INNATE AND MUCOSAL IMMUNITY DISCOVERY TEAM | |
| THOMAS JEFFERSON UNIVERSITY | ||||||||
| 125 SOUTH 9TH ST 2ND FLOOR SHERIDAN | PHILADELPHIA | PA | 19107 | 231352651 | 501(C)(3) | $469,870 | OVAF | BUILDING |
| NIHNICHD | ||||||||
| 9001 ROCKVILLE PIKE | BETHESDA | MD | 20893 | 520858116 | 170(C)(1) GOVT | $464,268 | RESEARCH | |
| COLORADO STATE UNIVERSITY | ||||||||
| 601 HOWES STREET-2002 CAMPUS | FORT COLLINS | CO | 80523 | 846000545 | 170(C)(1) GOVT | $435,319 | MOLECULAR MOSQUITOCIDES: DEVELOPMENT OF AN INNOVATIVE AND ROBUST, PLATFORM-BASED APPROACH FOR SUSTAINABLE INSECTICIDAL CONTROL OF ANOPHELINE MOSQUITOES | DELIVERY |
| VACCINE AND GENE THERAPY INSTITUTE FLORIDA | ||||||||
| 11350 SW VILLAGE PARKWAY THIRD | PORT ST LUCIE | FL | 34987 | 364631835 | 170(C)(1) GOVT | $432,016 | VIMC/INNATE AND MUCOSAL IMMUNITY DISCOVERY TEAM | FLOOR |
| DUKE UNIVERSITY | ||||||||
| 2200 WEST MAIN STREET SUITE 820 | DURHAM | NC | 27705 | 560532129 | 501(C)(3) | $350,549 | PROFICIENCY TESTING CENTRAL/CECI/BIOMARKERS | ERWIN SQUARE PLAZA |
| DONALD DANFORTH PLANT SCIENCE CENTER | ||||||||
| 975 NORTH WARSON ROAD | ST LOUIS | MO | 63132 | 311584621 | 501(C)(3) | $278,792 | REGULATORY DEVELOPMENT FOR HEG-MODIFIED MOSQUITOES | |
| NEW YORK BLOOD CENTER | ||||||||
| 310 EAST 67TH STREET | NEW YORK | NY | 10065 | 131949477 | 501(C)(3) | $198,887 | OVAF | |
| NIHNIDCD | ||||||||
| 9002 ROCKVILLE PIKE | BETHESDA | MD | 20894 | 520858117 | 170(C)(1) GOVT | $195,000 | RESEARCH | |
| BETH ISRAEL DEACONESS MEDICAL CENTER | ||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | 501(C)(3) | $124,176 | NON HUMAN PRIMATE NEW ASSAY | |
| THE HOPE FOUNDATION | ||||||||
| 24 FRANK LLOYD WRIGHT DR SUITE | ANN ARBOR | MI | 48106 | 742655302 | 501(C)(3) | $92,446 | LUNGMAP | 3600A |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 1620 TREMONT STREET 3RD FLOOR RM BC | BOSTON | MA | 02120 | 042312909 | 501(C)(3) | $89,616 | EVALUATION OF THE EFFECTS OF FCRN MUTATIONS ON ANTIBODY HALF-LIFE.+ KIDNEY | 3002 |
| FRIENDS OF CANCER RESEARCH | ||||||||
| 1800 M STREET NW SUITE 1050 SOUTH | WASHINGTON | DC | 20036 | 521983273 | 501(C)(3) | $75,000 | LUNG CANCER PROTOCOL | |
| NIHNEI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $69,412 | RESEARCH | |
| NIHNIEHS | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $50,000 | RESEARCH | |
| NIH- NCCAM | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $45,000 | RESEARCH | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 26 | Total501c3OrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | AWARDS | GrantTypeTxt |
| Recipient | 10 | RecipientCnt |
| Cash Grant | $130,650 | CashGrantAmt |
| Valuation Method Used | FMV | ValuationMethodUsedDesc |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS FOR-PROFIT INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. FELLOWS SELECTED FOR FOUNDATION FELLOWSHIPS ARE SELECTED THROUGH NATIONWIDE AND INTERNATIONAL COMPETITIONS. THE CLINICAL RESEARCH TRAINING PROGRAM (CRTP) IS OPEN TO ALL THIRD YEAR STUDENTS ENROLLED IN MEDICAL OR DENTAL SCHOOLS. THE WOMEN'S HEALTH FELLOWSHIP PROGRAMS ARE OPEN TO DOCTORAL-LEVEL CANDIDATES WITHIN FIVE YEARS OF RECEIPT OF THE DOCTORAL DEGREE. APPLICATIONS, CONTAINING TRANSCRIPTS AND ESSAYS ON THEIR RESEARCH GOALS ARE SUBMITTED AND REVIEWED BY PANELS OF NIH SCIENTISTS WHO MAKE RECOMMENDATIONS FOR SELECTION. POTENTIAL FELLOWS ARE OFTEN BROUGHT TO THE CAMPUS FOR INTERVIEWS AND FINAL SELECTION. THE FOUNDATION'S FELLOWSHIPS ARE OPEN TO PROFESSIONALS WORKING AT VARIOUS STAGES OF THEIR RESEARCH CAREERS. APPLICANTS TO THE NEUROSCIENCE FELLOWSHIP, FOR EXAMPLE, ARE YOUNG SCIENTISTS WHO WILL BENEFIT FROM EXPERIENCE OF CLINICAL AND BASIC SCIENCE RESEARCH. THE DIRECTOR'S FELLOWSHIP IN COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH SEEKS A MORE EXPERIENCED SCIENTIST WHO IS WELL-POSITIONED TO BECOME A LEADER IN THE FIELD OF COMPLEMENTARY ALTERNATIVE MEDICINE. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MARIA FREIRE PHD | ||||||||||||||
| PRESIDENT | $374,138 | $0 | $0 | $0 | $0 | $0 | $26,000 | $0 | $0 | $0 | $400,138 | $0 | $0 | $0 |
| ANDREA BARUCHIN | ||||||||||||||
| SR ADVISOR TO PRESIDENT | $199,343 | $0 | $0 | $0 | $200 | $0 | $19,934 | $0 | $5,316 | $0 | $224,793 | $0 | $0 | $0 |
| ANN ASHBY | ||||||||||||||
| DEPUTY EXECUTIVE DIRECTOR | $208,255 | $0 | $0 | $0 | $2,500 | $0 | $21,075 | $0 | $11,520 | $0 | $243,350 | $0 | $0 | $0 |
| DAVID WHOLLEY | ||||||||||||||
| DIR RESEARCH PARTNERSHIPS | $282,391 | $0 | $0 | $0 | $2,500 | $0 | $26,000 | $0 | $11,520 | $0 | $322,411 | $0 | $0 | $0 |
| JULIA WOLF-RODDA | ||||||||||||||
| DIR DEVELOPMENT | $187,834 | $0 | $0 | $0 | $0 | $0 | $18,783 | $0 | $11,520 | $0 | $218,137 | $0 | $0 | $0 |
| JULIE TUNE | ||||||||||||||
| CHIEF FINANCIAL OFFICER | $192,274 | $0 | $0 | $0 | $500 | $0 | $19,277 | $0 | $11,520 | $0 | $223,571 | $0 | $0 | $0 |
| STEPHANIE JAMES | ||||||||||||||
| DIR OF SCIENCE AND GCGH | $288,174 | $0 | $0 | $0 | $0 | $0 | $26,000 | $0 | $0 | $0 | $314,174 | $0 | $0 | $0 |
| GAIL LEVINE | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $146,886 | $0 | $0 | $0 | $2,500 | $0 | $14,939 | $0 | $11,520 | $0 | $175,845 | $0 | $0 | $0 |
| KAREN TOUNTAS | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $152,591 | $0 | $0 | $0 | $0 | $0 | $15,259 | $0 | $11,520 | $0 | $179,370 | $0 | $0 | $0 |
| MARIA VASSILEVA | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $130,760 | $0 | $0 | $0 | $6,200 | $0 | $13,696 | $0 | $11,520 | $0 | $162,176 | $0 | $0 | $0 |
| MICHAEL GOTTLIEB | ||||||||||||||
| ASSOC DIR OF SCIENCE | $234,143 | $0 | $0 | $0 | $0 | $0 | $23,414 | $0 | $0 | $0 | $257,557 | $0 | $0 | $0 |
| STEVE HOFFMAN | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $133,447 | $0 | $6,000 | $0 | $0 | $0 | $13,945 | $0 | $11,520 | $0 | $164,912 | $0 | $0 | $0 |
Schedule M IRS990ScheduleM
Drugs And Medical Supplies DrugsAndMedicalSuppliesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 2 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,492,479 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | MARKET PRICE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (11 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: | THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH. |
| FORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS: | PROGRAM ONE - RESEARCH PARTNERSHIPS - IN 2014, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH CONTINUED TO SUPPORT THE MISSION OF THE NIH, FORGING NEW MODELS OF COLLABORATION FOCUSED ON THE GOAL OF ADVANCING BIOMEDICAL SCIENCE TO IMPROVE LIVES. FNIH INITIATIVES BRING TOGETHER GOVERNMENT AGENCIES, FOUNDATIONS, NON-PROFITS, CORPORATIONS AND ACADEMIA IN A WIDE PORTFOLIO OF PROGRAMS TO UNDERSTAND DISEASE, SUPPORT NIH RESEARCH, ENHANCE GLOBAL HEALTH, DEVELOP THE CAREERS OF YOUNGER RESEARCHERS, RECOGNIZE SCIENTIFIC ACHIEVEMENT, EDUCATE THE PUBLIC ABOUT SCIENCE AND MUCH MORE. AMONG THE FNIH PROGRAMS ARE: ACCELERATING MEDICINES PARTNERSHIP (AMP) NEW MEDICINES THAT SHOW PROMISE IN THE LABORATORY OFTEN DO NOT SUCCEED IN HUMAN TESTING. IN FACT, ABOUT 95 PERCENT FAIL, TYPICALLY LATE IN THE CLINICAL TRIALS PROCESS AFTER MILLIONS OF DOLLARS HAVE BEEN INVESTED. SUCH A HIGH-COST, LOW-REWARD PIPELINE POINTS TO THE NEED FOR A BETTER UNDERSTANDING OF HOW DISEASES DEVELOP AT THE MOLECULAR LEVEL-WHICH IS WHY THE FNIH IS HELPING TO LEAD AN UNPRECEDENTED PARTNERSHIP TO FILL THIS NEED. LAUNCHED IN 2014, THE ACCELERATING MEDICINES PARTNERSHIP (AMP) IS A $230 MILLION, FIVE-YEAR EFFORT JOINING THE FORCES OF THE FNIH, THE NIH AND THE FOOD AND DRUG ADMINISTRATION (FDA) WITH THOSE OF NOT-FOR-PROFIT ORGANIZATIONS AND 10 BIOPHARMACEUTICAL COMPANIES TO DEVISE A RADICALLY NEW APPROACH TO EARLY-STAGE DRUG DEVELOPMENT. THESE COMPANIES HAVE AGREED TO SHARE EXPERTISE, RESOURCES AND DATA TO ANSWER A CRITICAL QUESTION: WHICH BIOLOGICAL PATHWAYS UNDERLYING A GIVEN DISEASE ARE THE BEST CANDIDATES FOR TARGETING NEW TREATMENTS? INSTEAD OF HAVING DIFFERENT ORGANIZATIONS PURSUE DISPARATE PATHWAYS IN ISOLATION, AMP WILL GENERATE PRE-COMPETITIVE, DISEASE-SPECIFIC DATA ON THE GENETIC AND BIOLOGICAL MARKERS MOST LIKELY TO YIELD SUCCESS WHEN USED AS TARGETS FOR NEW MEDICINES. THE DATA WILL BE PUBLICLY AVAILABLE TO THE BIOMEDICAL COMMUNITY SO THAT MANY CAN USE IT AS THE FOUNDATION FOR DRUG DISCOVERY. AMP: TYPE 2 DIABETES MORE THAN 100 MILLION AMERICANS ALREADY HAVE TYPE 2 DIABETES OR ARE AT HIGH RISK, AND 382 MILLION PEOPLE WORLDWIDE HAVE A TYPE 2 DIAGNOSIS. ALTHOUGH THERAPIES ARE AVAILABLE, NONE CAN REVERSE THE DISEASE PROCESS OR PREVENT THE PROGRESSION THAT LEADS TO LIFE-ALTERING COMPLICATIONS SUCH AS CARDIOVASCULAR AND KIDNEY DISEASE, LIMB LOSS AND BLINDNESS. AMP PARTNERS WILL LEVERAGE THE SUBSTANTIAL AMOUNT OF DATA ALREADY AVAILABLE FROM PATIENTS WITH TYPE 2 DIABETES AND THOSE AT HIGH RISK TO IDENTIFY AND VALIDATE DNA REGIONS CRITICAL IN THE DEVELOPMENT OR PROGRESSION OF THE DISEASE, WITH AN EYE TOWARD IDENTIFYING POTENTIAL DRUG TARGETS. AMP: ALZHEIMER'S DISEASE ALZHEIMER'S DISEASE (AD) IS THE MOST COMMON FORM OF DEMENTIA, A CONDITION THAT AFFECTS 36 MILLION PEOPLE GLOBALLY-A NUMBER EXPECTED TO SKYROCKET TO 115 MILLION BY 2050 UNLESS AN EFFECTIVE THERAPY IS DEVELOPED. SCIENTISTS KNOW THAT PEOPLE WITH AD HAVE THE SIGNATURE PROTEIN- BASED BRAIN LESIONS CALLED PLAQUES AND TANGLES; HOWEVER, EFFORTS TO HARNESS THIS KNOWLEDGE TO DEVELOP NEW THERAPIES HAVE NOT SUCCEEDED. AMP PARTNERS ARE WORKING TO ESTABLISH AN EXPANDED SET OF BIOLOGICAL MARKERS THAT ARE PRESENT WHEN AD DEVELOPS, AND THEN DETERMINE WHICH ARE MOST PROMISING FOR DEVELOPING NEW TREATMENTS AND PREDICTING THE LIKELIHOOD OF CLINICAL RESPONSE. THE PROJECT WILL INVOLVE THE LARGE-SCALE ANALYSIS OF BRAIN TISSUE FROM AD PATIENTS AND CLINICAL TRIALS TO VALIDATE NEWLY IDENTIFIED BIOMARKERS. AMP: RHEUMATOID ARTHRITIS & LUPUS RHEUMATOID ARTHRITIS (RA) AND LUPUS ARE JUST TWO OF MANY DISORDERS THAT OCCUR WHEN THE IMMUNE SYSTEM MISTAKENLY ATTACKS PARTS OF THE BODY THAT IT IS DESIGNED TO PROTECT, LEADING TO INFLAMMATION THAT DESTROYS TISSUES. ANTI-INFLAMMATORY TREATMENTS CAN HELP, BUT MOST PEOPLE WITH RA RESPOND TO CURRENT TREATMENTS ONLY PARTIALLY OR TEMPORARILY. IN THE CASE OF LUPUS, NO EFFECTIVE TARGETED THERAPIES EXIST FOR THE MOST SEVERE FORMS OF THE DISEASE. AMP PARTNERS WILL ANALYZE TISSUE AND BLOOD SAMPLES FROM PEOPLE WITH RA AND LUPUS TO PINPOINT GENES, PROTEINS, CHEMICAL PATHWAYS AND NETWORKS INVOLVED AT THE CELLULAR LEVEL. THIS IS ESSENTIAL FOR DEVELOPING TARGETED TREATMENTS FOR THESE DEBILITATING CONDITIONS, BUT IT ALSO COULD SHED LIGHT ON THE AUTOIMMUNE PROCESS IMPLICATED IN A WIDE RANGE OF DISEASES. THE LUNG CANCER MASTER PROTOCOL PATIENTS WITH ADVANCED SQUAMOUS CELL LUNG CANCER HAVE FEW GOOD TREATMENT OPTIONS BEYOND SURGERY, YET THE PACE OF TRADITIONAL CLINICAL TRIALS REMAINS SLOW, WITH MOST POTENTIAL TREATMENTS NEVER MAKING IT TO THE BEDSIDE. THE LUNG CANCER MASTER PROTOCOL (LUNG-MAP) TRIAL, THE RESULT OF A PARTNERSHIP THAT INCLUDES THE FNIH, IS PIONEERING A NEW MODEL DESIGNED TO SPEED ACCESS TO INVESTIGATIONAL DRUGS FOR PATIENTS AND ALLOW MULTIPLE RESEARCHERS TO SHARE ONE UMBRELLA STRUCTURE AND RECRUITMENT PROCESS, SIGNIFICANTLY INCREASING THEIR EFFICIENCY. LAUNCHED IN JUNE 2014, LUNG-MAP USES GENOMIC PROFILING TECHNOLOGY TO TEST PATIENTS FOR OVER 200 CANCER-RELATED GENETIC ALTERATIONS, THEN ASSIGNS THEM TO ONE OF A NUMBER OF INVESTIGATIONAL TREATMENT STUDIES BASED ON THEIR GENETIC PROFILE. WITHIN ITS FIRST SIX MONTHS, LUNG-MAP WAS ENROLLING PATIENTS AT MORE THAN 400 SITES IN 39 STATES. THE TRIAL WILL ADD NEW INVESTIGATIONAL TREATMENTS OVER TIME, WITH THE ULTIMATE GOAL OF TESTING 10 TO 12 TARGETED THERAPIES IN 5,000 PATIENTS OVER THE NEXT FIVE YEARS. BESIDES THE FNIH, PARTNERS IN THE EFFORT INCLUDE THE NATIONAL CANCER INSTITUTE, SWOG CANCER RESEARCH, FRIENDS OF CANCER RESEARCH, FOUNDATION MEDICINE, FIVE PHARMACEUTICAL COMPANIES AND SEVERAL LUNG CANCER ADVOCACY GROUPS. CONSENSUS DEFINITION OF CLINICALLY IMPORTANT SARCOPENIA. SARCOPENIA-AGE-RELATED MUSCLE LOSS AND WEAKNESS-AFFECTS NEARLY 1 IN 3 PEOPLE OVER 60 AND HALF OF THOSE OVER AGE 80. HOWEVER, LACK OF AN EVIDENCE-BASED DEFINITION FOR SARCOPENIA HAS LIMITED OUR ABILITY TO UNDERSTAND ITS PROGRESSION AND DEVELOP STRATEGIES FOR PREVENTION AND TREATMENT. THIS CHANGED IN APRIL 2014 WITH THE LANDMARK PUBLICATION OF SIX SPECIAL ONLINE ARTICLES IN THE JOURNALS OF GERONTOLOGY: MEDICAL SCIENCES, WHICH SET FORTH DATA-DRIVEN DIAGNOSTIC CRITERIA FOR SARCOPENIA, INCLUDING DEFINITIONS OF GRIP STRENGTH AND MUSCLE MASS. THE ARTICLES RESULTED FROM A COLLABORATIVE PROJECT BY THE FNIH BIOMARKERS CONSORTIUM, THE FDA, THE NATIONAL INSTITUTE ON AGING AND SEVERAL PHARMACEUTICAL COMPANIES, IN WHICH RESEARCHERS ANALYZED DATA FROM NINE LONG-TERM EPIDEMIOLOGIC STUDIES INVOLVING OVER 26,000 HEALTHY PARTICIPANTS TO GENERATE A DEFINITION OF SARCOPENIA. IN ADDITION TO DIAGNOSTIC CRITERIA, THE 2014 PUBLICATIONS PROVIDE SPECIFIC CHARACTERIZATIONS OF HOW LOW LEAN MASS AND LOW STRENGTH RELATE TO PROBLEMS WITH MOBILITY. THIS NEW INFORMATION IS EXPECTED TO INFLUENCE TREATMENT DECISIONS AND HELP IDENTIFY GROUPS OF AT-RISK PATIENTS WHO ARE GOOD CANDIDATES FOR TESTING INTERVENTIONS. RIVER BLINDNESS: MOVING BEYOND CONTROL TO ELIMINATION OVER THE PAST FEW DECADES, FOCUSED EFFORTS TO CONTROL THE TROPICAL DISEASE ONCHOCERCIASIS, OR RIVER BLINDNESS, HAVE DRASTICALLY LOWERED INCIDENCE IN SOUTH AND CENTRAL AMERICA, BUT THE DISEASE CONTINUES TO HAVE A DEVASTATING IMPACT IN SUB-SAHARAN AFRICA. RIVER BLINDNESS IS CAUSED BY ONCHOCERCA VOLVULUS WORMS, WHICH ARE TRANSMITTED TO HUMANS THROUGH REPEATED BITES FROM INFECTED BLACKFLIES. MASS ADMINISTRATION OF THE DRUG IVERMECTIN IS AN EFFECTIVE CONTROL STRATEGY, BUT IT DOES NOT GUARANTEE ELIMINATION OF THE DISEASE FROM A POPULATION, AS PEOPLE CAN CARRY THE WORMS WITHOUT EXHIBITING SYMPTOMS. THE FNIH IS WORKING WITH THE NIAID TO DETERMINE IF A BLOOD OR URINE TEST COULD BE DEVELOPED TO IDENTIFY PEOPLE WHO ARE CARRIERS OF ADULT FEMALE ONCHOCERCA VOLVULUS WORMS (OVAF). ONCE INSIDE A HUMAN HOST, THESE FEMALES PRODUCE SMALLER LARVAE THAT OVER TIME CAN CAUSE CHRONIC SKIN DISEASE, SEVERE ITCHING AND EYE LESIONS THAT LEAD TO BLINDNESS. KNOWING IF SOMEONE IS A CARRIER WOULD ENSURE THEY COULD BE TREATED AND PREVENT TRANSMISSION OF THE WORMS TO UNINFECTED BLACKFLIES. THE FNIH AND NIAID ARE STUDYING OVAF AND OVAF-INFECTED HUMANS TO IDENTIFY BIOMARKERS IN BLOOD AND URINE THAT MIGHT INDICATE THE PRESENCE OF THE FEMALE WORM, AND THEN TEST AND VALIDATE THE MOST PROMISING CANDIDATES. THE ULTIMATE GOAL IS A POINT-OF-CARE TEST THAT WOULD HELP ERADICATE RIVER BLINDNESS AROUND THE GLOBE. |
| FORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS: | THE WORK OF THE FNIH ALSO INCLUDES INITIATIVES AND STUDIES IN NUMEROUS OTHER AREAS, INCLUDING: ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE AS THE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) APPROACHES THE END OF ITS FIRST DECADE, THE PARTNERSHIP REMAINS A GOLD STANDARD FOR HOW ACADEMIC, INDUSTRY, ADVOCACY AND GOVERNMENT PARTNERS CAN, TOGETHER, ADVANCE BIOMEDICAL RESEARCH. INVOLVING MORE THAN 25 PARTNERS COORDINATED BY FNIH, ADNI CREATED AN ONLINE, OPEN-ACCESS DATABASE AND IMAGE ARCHIVE FOR ALL INFORMATION COLLECTED BY RESEARCHERS. IN ADNI PHASE 1, THE STUDY PERFORMED MRI AND PET SCANS AND COLLECTED CEREBROSPINAL FLUID AND OTHER BIOSAMPLES FROM 1,500 PARTICIPANTS. PHASE 2, WHICH WILL CONTINUE THROUGH 2015, FOLLOWS PHASE 1 PARTICIPANTS AND HAS ENROLLED AN ADDITIONAL 750 PEOPLE. THE STUDY HAS ALSO EXPANDED TO INCLUDE GENETIC TESTING, INCLUDING WHOLE-GENOME SEQUENCING FOR MORE THAN 800 PARTICIPANTS. SPIROMICS CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), WHICH INCLUDES CHRONIC BRONCHITIS AND EMPHYSEMA, AFFECTS MORE THAN 12 MILLION AMERICANS AND IS THE COUNTRY'S THIRD LEADING CAUSE OF DEATH. THE DISEASE PROGRESSES OVER TIME, SUGGESTING THAT THERE MAY BE POINTS FOR EARLY INTERVENTION TO PREVENT FULL-BLOWN COPD FROM DEVELOPING. HOWEVER, WE DO NOT UNDERSTAND THE DISEASE'S CLINICAL COURSE WELL ENOUGH TO MAKE THAT HAPPEN. THE SPIROMICS (SUBPOPULATIONS AND INTERMEDIATE OUTCOME MEASURES IN COPD STUDY) PROGRAM BRINGS TOGETHER THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE, THE FOOD AND DRUG ADMINISTRATION, INDUSTRY PARTNERS AND MULTIPLE RESEARCHERS ACROSS THE COUNTRY. THE STUDY IS ENROLLING SUBJECTS WITH COPD AT 11 SITES NATIONALLY AND COLLECTING BLOOD SAMPLES, IMAGES, LUNG FUNCTION TESTS AND GENETIC INFORMATION. FNIH COORDINATES THE SPIROMICS EXTERNAL SCIENTIFIC BOARD. GLOBAL HEALTH COLLABORATING WITH ORGANIZATIONS AROUND THE WORLD, FNIH FURTHERS THE UNDERSTANDING AND CONTROL OF DISEASES THAT SICKEN AND KILL HUNDREDS OF MILLIONS OF PEOPLE EVERY YEAR. WORKING IN THE U.S. AND INTERNATIONALLY, FNIH-FUNDED INVESTIGATORS ARE MAKING STRIDES AGAINST LIFE-THREATENING DISEASES INCLUDING MALARIA, DENGUE, TUBERCULOSIS, ENTERIC INFECTIONS AND MALNUTRITION. GRAND CHALLENGES IN GLOBAL HEALTH FOUND IN 100 COUNTRIES, WITH NO VACCINE AND NO CURE, THE MOSQUITO-BORNE VIRAL DISEASE KNOWN A DENGUE FEVER IS A SIGNIFICANT GLOBAL HEALTH THREAT. USING INSECTICIDES TO CONTROL POPULATIONS OF THE FEMALE AEDES AEGYPTI MOSQUITO, WHICH SPREADS THE VIRUS, HAS FAILED TO STOP DENGUE; IN FACT, INCIDENCE HAS INCREASED 30-FOLD IN THE LAST 50 YEARS. THE FNIH'S GRAND CHALLENGES IN GLOBAL HEALTH, AN INITIATIVE FUNDED BY THE BILL & MELINDA GATES FOUNDATION, IS SUPPORTING A GLOBAL NETWORK OF RESEARCHERS WHO HAVE FOUND THAT INFECTING THE MOSQUITOES WITH WOLBACHIA, A COMMON BACTERIUM FOUND IN MANY INSECTS, CAN REDUCE MOSQUITOES' ABILITY TO TRANSMIT THE VIRUS. THE METHOD, WHICH HAS SHOWN GREAT PROMISE THROUGH A SERIES OF TEST RELEASES, IS PART OF ELIMINATE DENGUE, ONE OF SEVERAL PROJECTS THAT ARE PART OF THE FNIH'S VECTOR-BASED CONTROL OF TRANSMISSION: DISCOVER RESEARCH (VCTR) PROGRAM, AN OFFSHOOT OF THE GRAND CHALLENGES INITIATIVE. MAL-ED THE $40 MILLION MAL-ED NETWORK, A COLLABORATIVE PROJECT SUPPORTED BY THE BILL & MELINDA GATES FOUNDATION AND MANAGED BY THE FNIH IN COOPERATING WITH THE NIH FOGARTY INTERNATIONAL CENTER, SUPPORTS RESEARCHERS AT EIGHT FIELD SITES IN AFRICA, ASIA AND SOUTH AMERICA, WHO HAVE BEEN FOLLOWING MORE THAN 1,600 CHILDREN SINCE BIRTH, TO UNDERSTAND HOW ENTERIC PATHOGENS, NUTRITION AND OTHER ENVIRONMENTAL FACTORS ARE LINKED TO PHYSICAL GROWTH, COGNITIVE DEVELOPMENT AND VACCINE RESPONSE. IDENTIFYING BIOMARKERS THAT PREDICT GROWTH FALTERING AND/OR IMPAIRED COGNITIVE DEVELOPMENT WILL INFORM DEVELOPMENT OF STRATEGIES FOR TIMELY INTERVENTION. |
| FORM 990, PART III, LINE 4B, PROGRAM SERVICE ACCOMPLISHMENTS: | PROGRAM TWO - FELLOWSHIPS AND TRAINING PROGRAMS - WHILE TECHNOLOGY PLAYS AN INCREASINGLY VITAL ROLE IN ADVANCING HUMAN HEALTH, PROGRESS IS IMPOSSIBLE WITHOUT A NEW GENERATION OF CAPABLE AND CURIOUS RESEARCHERS. FNIH PROGRAMS IN VARIOUS FORMATS TARGET A WIDE ARRAY OF TOPICS AND EDUCATION LEVELS, MAKING THE WORLD-CLASS METHODS AND RESOURCES OF THE NIH AVAILABLE TO STUDENTS AND RESEARCHERS ALL OVER THE WORLD. EXAMPLES INCLUDE: MEDICAL RESEARCH SCHOLARS PROGRAM. THE MEDICAL RESEARCH SCHOLARS PROGRAM BRINGS TO THE NIH CAMPUS SOME OF THE BEST AND BRIGHTEST YOUNG RESEARCHERS FROM MEDICAL, DENTAL AND VETERINARY SCHOOLS ACROSS THE COUNTRY. DURING THE YEAR-LONG PROGRAM, THE STUDENTS CONDUCT BASIC, TRANSLATIONAL OR CLINICAL RESEARCH IN A FIELD OF THEIR CHOICE, GUIDED BY A MENTOR AND A TUTOR. THE PROGRAM IMMERSES STUDENTS IN BIOMEDICAL RESEARCH EARLY IN THEIR CAREER TRAINING. IN ADDITION TO THEIR RESEARCH WORK, STUDENTS COMPLETE AN ACADEMIC CURRICULUM AND INTERACT WITH NIH SCIENTIFIC LEADERS, INCLUDING INSTITUTE DIRECTORS, CLINICAL DIRECTORS AND ESTABLISHED INVESTIGATORS. THE PROGRAM MERGES AND BUILDS ON TWO EARLIER, HIGHLY SUCCESSFUL TRAINING PROGRAMS, THE HOWARD HUGHES MEDICAL INSTITUTE-NIH RESEARCH SCHOLARS PROGRAM AND THE CLINICAL RESEARCH TRAINING PROGRAM. THE GOAL IS TO SUPPORT 70 SCHOLARS EACH YEAR. HUMAN GENOME EXHIBITION. BETWEEN JUNE 2013 AND AUGUST 2014, ROUGHLY THREE MILLION SMITHSONIAN VISITORS EXPERIENCED GENOME: UNLOCKING LIFE'S CODE AT THE NATIONAL MUSEUM OF NATURAL HISTORY, AN EXHIBITION MADE POSSIBLE THROUGH FUNDS RAISED, IN PART, BY THE FNIH. THE RESULT OF A COLLABORATION BETWEEN THE MUSEUM AND THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE, GENOME AWED VISITORS WITH THE COMPLEXITY AND POWER OF THE HUMAN GENOME USING 3-D MODELS, INTERACTIVE DISPLAYS, CUSTOM ANIMATIONS AND VIDEOS OF REAL-LIFE STORIES. IT CELEBRATED THE 10TH ANNIVERSARY OF THE HUMAN GENOME PROJECT AND THE SUCCESSFUL SEQUENCING OF THE HUMAN GENETIC BLUEPRINT, HELPING VIEWERS UNDERSTAND HOW THIS KNOWLEDGE IS REVOLUTIONIZING OUR UNDERSTANDING OF HUMAN DEVELOPMENT, DIVERSITY AND SOCIETY, ESPECIALLY HEALTH AND DISEASE. IN ADDITION TO THE 4,400-SQUARE-FOOT EXHIBITION ITSELF, WHICH TOOK TWO YEARS FOR MUSEUM DESIGNERS AND EDUCATORS TO DEVELOP AND BUILD, GENOME INCLUDED PUBLIC EVENTS, EDUCATIONAL SYMPOSIA, AN EDUCATORS' GUIDE AND THE WEBSITE WWW.UNLOCKINGLIFESCODE.ORG. GENOME IS NOW ON A MULTI-CITY TOUR THAT WILL TAKE IT TO MUSEUMS IN CALIFORNIA, THE MIDWEST AND ONTARIO THROUGH EARLY 2018. HONORS. WHAT IF WE COULD REMOVE AND REPLACE DAMAGED OR DEFECTIVE PARTS OF HUMAN DNA? SCIENTISTS HAVE BEEN WORKING TO FIND SUCH A GENOME-EDITING TOOL, BUT JENNIFER DOUDNA, PH.D., PROFESSOR OF BIOCHEMISTRY, BIOPHYSICS AND STRUCTURAL BIOLOGY AND A HOWARD HUGHES MEDICAL INSTITUTE INVESTIGATOR AT THE UNIVERSITY OF CALIFORNIA, BERKELEY, STANDS APART. DR. DOUDNA HAS FOCUSED HER RESEARCH ON THE STRUCTURE OF RNA, THE MOLECULE THAT CARRIES OUT DNA INSTRUCTIONS FOR CREATING THE PROTEINS THAT DRIVE PROCESSES IN THE BODY. THE FNIH AWARDED HER THE LURIE PRIZE IN BIOMEDICAL SCIENCES IN 2014 FOR THAT BODY OF STUDY, WHICH INCLUDES HER WORK ON CRISPR (CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS), THAT ARE REPETITIVE RNA SEQUENCES IN BACTERIA THAT PLAY A ROLE IN THEIR IMMUNITY. DOUDNA DISCOVERED THAT PIECES OF CRISPR RNA TEAM UP WITH A PROTEIN CALLED CAS9 TO CUT THROUGH THE DNA OF AN INVADING VIRUS. DOUDNA AND HER TEAM THEN ENGINEERED THEIR OWN RNA/PROTEIN COMBINATION AND SHOWED IT CAN BE USED TO PRECISELY EDIT THE DNA OF PLANTS, ANIMALS AND HUMANS. THIS CRISPR TOOL HAS TO BE MANAGED WITH CAREFUL ATTENTION TO BIOETHICAL CONCERNS, BUT IT COULD FUNCTION AS "MOLECULAR SCISSORS" THAT CAN FIX FAULTY GENES UNDERLYING A RANGE OF DISEASES AND HEALTH CONDITIONS. |
| FORM 990, PART III, LINE 4C, PROGRAM SERVICE ACCOMPLISHMENTS: | PROGRAM THREE - CAPITAL PROJECTS - THE FOUNDATION'S CAPITAL PROJECTS ENHANCE THE RESEARCH ENVIRONMENT AT NIH, SUPPORTING AND PROMOTING THE IMPORTANT DISCOVERIES THAT RESULT FROM NIH'S LEADING-EDGE WORK. THE EDMOND J. SAFRA FAMILY LODGE, FOR EXAMPLE, OPENED IN 2005 TO SERVE AS A COMFORTABLE HOME-AWAY-FROM-HOME FOR FAMILIES THAT COME TO NIH'S CAMPUS IN BETHESDA, MARYLAND TO ACCOMPANY PATIENTS WHO ARE PARTICIPATING IN CLINICAL TRIALS OR RECEIVING TREATMENT AT NIH'S CLINICAL CENTER. SO FAR, THE LODGE HAS HOSTED MORE THAN 40,000 FAMILY MEMBERS AND CAREGIVERS OF ADULT PATIENTS FROM ALL OVER THE WORLD. |
| FORM 990, PART III, LINE 4D, OTHER PROGRAM SERVICES: | MEMORIALS, AWARDS AND EVENTS - COLLABORATION HAPPENS WHEN PEOPLE CONNECT. THAT IS WHY MANAGING AND ORGANIZING MEETINGS AND EVENTS IS FUNDAMENTAL TO THE WORK OF THE FNIH. FROM LECTURES AND WORKSHOPS TO COLLABORATIVE SUMMITS, TELECONFERENCES AND MEDIA OPPORTUNITIES, THE FNIH FACILITATED MORE THAN 60 EVENTS IN 2014 - SPANNING THE GLOBE AND DOZENS OF FIELDS OF RESEARCH. |
| FORM 990, PART VI, SECTION B, LINE 11 | PRIOR TO THE SUBMISSION OF THE FOUNDATION FOR NIH'S FORM 990 TO THE INTERNAL REVENUE SERVICE, EACH VOTING MEMBER OF THE BOARD OF DIRECTORS SHALL BE PROVIDED WITH A COPY OF THE FINAL FORM 990 AS COMPLETED BY THE CHIEF FINANCIAL OFFICER. BOARD DIRECTORS SHALL BE PROVIDED WITH AT LEAST TEN BUSINESS DAYS TO REVIEW THE FORM AND RAISE QUESTIONS, MAKE SUGGESTIONS, AND ADDRESS ANY POTENTIAL PROBLEMS OR CONCERNS WITH THE CHIEF FINANCIAL OFFICER. A SPECIAL MEETING OF THE GOVERNANCE COMMITTEE WILL BE CALLED TO REVIEW THE SUGGESTED CHANGES FROM THE BOARD OF DIRECTORS AND TO APPROVE THE FINAL VERSION OF THE FORM 990 FOR SUBMISSION. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE FOUNDATION REQUIRES DIRECTORS, OFFICERS, VOLUNTEER COMMITTEE MEMBERS, AND STAFF MEMBERS TO DISCLOSE REAL AND APPARENT CONFLICTS OF INTEREST FOR THEMSELVES AND THEIR FAMILY MEMBERS AND TO ANNUALLY SIGN A STATEMENT OF COMPLIANCE. AFTER A CONFLICT OR AN APPARENT CONFLICT OF INTEREST HAS BEEN DISCLOSED, THE BOARD OF DIRECTORS OR THE BOARD COMMITTEE, OR THEIR DESIGNEE, IN THE ABSENCE OF THE INTERESTED PERSON, SHALL DETERMINE IF THE CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST EXISTS AND IS MATERIAL AND WILL DECIDE HOW IT IS TO BE MANAGED OR ELIMINATED. |
| FORM 990, PART VI, SECTION B, LINE 15 | BEGINNING IN 2015, THE NEWLY CREATED COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS WILL REVIEW AND APPROVE THE SALARIES OF THE EXECUTIVE DIRECTOR AND KEY EMPLOYEES ANNUALLY. |
| FORM 990, PART VI, SECTION C, LINE 19 | ALL DOCUMENTS ARE AVAILABLE UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS ARE POSTED TO THE ORGANIZATION'S WEBSITE. |
| FORM 990, PART XII, LINE 2C: | PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. |